Ischemic Attack, TransientPlatelet Aggregation InhibitorsTiclopidineAspirinStrokeHemorrhageDrug Therapy, CombinationThrombosisPlatelet Function TestsAnticoagulantsPlatelet AggregationStentsCoronary ThrombosisCerebrovascular DisordersPurinergic P2Y Receptor AntagonistsPhenprocoumonTreatment OutcomeReceptors, Purinergic P2Y12Acute Coronary SyndromeDipyridamoleDrug-Eluting StentsRisk FactorsAngioplasty, Balloon, CoronaryTime FactorsBrain IschemiaFibrinolytic AgentsThiophenesBlood PlateletsFollow-Up StudiesWarfarinProspective StudiesMyocardial InfarctionRecurrencePlatelet ActivationSecondary PreventionThienopyridinesCarotid StenosisEndarterectomy, CarotidRisk AssessmentCarotid Artery DiseasesEmbolismTetrazolesThromboembolismCoronary Artery DiseasePlatelet Glycoprotein GPIIb-IIIa ComplexRetrospective StudiesIntracranial EmbolismCerebral HemorrhagePercutaneous Coronary InterventionIntracranial HemorrhagesRandomized Controlled Trials as TopicIntracranial ThrombosisCerebral AngiographyPostoperative HemorrhageAtrial FibrillationCerebral InfarctionDrug ResistanceIncidenceRegistriesPerioperative CareEndarterectomyCoronary RestenosisCarotid ArteriesThrombelastographyCoronary DiseaseIntracranial ArteriosclerosisCohort StudiesSirolimusAdministration, OralPostoperative ComplicationsGraft Occlusion, VascularPyridinesPlatelet CountArterial Occlusive DiseasesCardiovascular DiseasesTomography, X-Ray ComputedPiperazinesPeripheral Vascular DiseasesAngioplastyPurinergic P2 Receptor AntagonistsProsthesis DesignRiskCoronary AngiographyDouble-Blind MethodSulfinpyrazoneUltrasonography, Doppler, TranscranialCarotid Artery, InternalHeparinAcenocoumarolClinical Trials as TopicIntracranial Embolism and ThrombosisPredictive Value of TestsIntracranial Arterial DiseasesNeurologyDrug Administration ScheduleInternational Normalized RatioMyocardial IschemiaMoyamoya DiseasePractice Guidelines as TopicThromboxanes